Toshimasa Kukita

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 116 citations · Full text

Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.

Kosei Arimura, Hirosaka Inoue, Toshimasa Kukita et al. · PubMed · 2005 · 56 citations

Acute Lung Injury, Immunology, Immunotherapy +21

Long-term Maintenance Combination Chemotherapy with OPECMPEC (Vincristine or Methotrexate, Prednisolone, Etoposide and Cyclophosphamide) or with Daily Oral Etoposide and Prednisolone Can Improve Survival and Quality of Life in Adult T-cell LeukemiaLymphoma

Kakushi Matsushita, Tadashi Matsumoto, Hideo Ohtsubo et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1999 · 40 citations

Hematological Malignancy, Lymphoid Neoplasia, Adult T-cell Leukemialymphoma +15

NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications

Naomichi Arima, Kakushi Matsushita, Hachiro Obata et al. · Experimental Hematology · 1999 · 35 citations · Full text

Clinical Implications, Cancer Immunosurveillance, Nf-κb Involvement +9

FDG PET Findings of Chronic Myeloid Leukemia in the Chronic Phase Before and After Treatment

Masatoyo Nakajo, Seishi Jinnouchi, Hirosaka Inoue et al. · Clinical Nuclear Medicine · 2007 · 30 citations

Positron Emission Tomography, Hematological Malignancy, Fdg Pet Findings +15